Who owns ATHIRA PHARMA INC?
- Ticker: ATHA
- CUSIP Number: 04746l104
Tip: Access positions for across all investors
Analyze quarterly positions in Athira Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Athira Pharma stock
Who bought or sold ATHIRA PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 5.4M | $13M | 13% | Dec 2023 |
|
| Baker Bros. Advisors | 3.2M | $7.7M | 0% | Dec 2023 |
|
| Vanguard Group | 1.7M | $4.1M | 0% | Dec 2023 |
|
| Simplify Asset Management | 1.5M | $3.6M | 0% | Dec 2023 |
|
| Propel Bio Management | 1.5M | $3.6M | 100% | Dec 2023 |
|
| BML Capital Management | 1.5M | $3.5M | -15% | Dec 2023 |
|
| Tang Capital Management | 1.2M | $2.8M | 227% | Dec 2023 |
|
| Millennium Management | 456k | $1.1M | -39% | Dec 2023 |
|
| Pathstone Holdings | 372k | $905k | 100% | Dec 2023 |
|
| Citadel Advisors | 366k | $890k | -3% | Dec 2023 |
|
| Dimensional Fund Advisors | 347k | $843k | -35% | Dec 2023 |
|
| Two Sigma Investments | 304k | $739k | 14% | Dec 2023 |
|
| GSA Capital Partners | 301k | $731k | 1% | Dec 2023 |
|
| Two Sigma Advisers | 299k | $726k | 7% | Dec 2023 |
|
| Jacobs Levy Equity Management | 270k | $657k | -10% | Dec 2023 |
|
| Barclays | 174k | $440k | -60% | Dec 2023 |
|
| Advisor Group Holdings | 170k | $413k | 20% | Dec 2023 |
|
| Potomac Capital Management | 150k | $364k | 101% | Dec 2023 |
|
| Bristlecone Advisors | 85k | $207k | 0% | Dec 2023 |
|
| CornerCap Investment Counsel | 75k | $183k | 0% | Dec 2023 |
|
| Clarius | 54k | $147k | 0% | Mar 2024 |
|
| Bank of America Corporation | 49k | $118k | -89% | Dec 2023 |
|
| William Blair $ Company | 36k | $88k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 36k | $92k | 1740% | Dec 2023 |
|
| Levin Easterly Partners | 34k | $81k | 0% | Dec 2023 |
|
| Integrity Financial Corp | 33k | $80k | 0% | Dec 2023 |
|
| Jane Street | 23k | $55k | 100% | Dec 2023 |
|
| Mirador Capital Partners | 21k | $57k | 100% | Mar 2024 |
|
| Massey, Quick & Co | 21k | $50k | 0% | Dec 2023 |
|
| Journey Strategic Wealth | 21k | $50k | 0% | Dec 2023 |
|
| Sargent Investment Group | 18k | $44k | -12% | Dec 2023 |
|
| Cubist Systematic Strategies | 17k | $41k | -14% | Dec 2023 |
|
| Bank of New York Mellon | 16k | $39k | 0% | Dec 2023 |
|
| Occudo Quantitative Strategies | 16k | $38k | -26% | Dec 2023 |
|
| Federated Investors | 14k | $34k | -6% | Dec 2023 |
|
| Private Advisor | 13k | $32k | 100% | Dec 2023 |
|
| HighTower Advisors | 13k | $30k | -1% | Dec 2023 |
|
| Lindbrook Capital | 9.7k | $24k | 0% | Dec 2023 |
|
| Point72 Asia | 3.1k | $7.5k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 1.5k | $3.7k | 0% | Dec 2023 |
|
| American Capital Advisory | 1.0k | $2.4k | 100% | Dec 2023 |
|
| UBS Group | 932.00 | $2.3k | -99% | Dec 2023 |
|
| McIlrath & Eck | 825.00 | $2.0k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 234.00 | $568.994400 | -98% | Dec 2023 |
|
| Mather Group | 175.00 | $425.005000 | 100% | Mar 2024 |
|
| Householder Group Estate & Retirement Specialist | 150.00 | $0 | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 143.00 | $347.003800 | -86% | Dec 2023 |
|
| Citigroup | 75.00 | $182.002500 | 0% | Dec 2023 |
|
Who sold out of Athira Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Sep 2023 | 908k | $1.8M |
| Acuitas Investments | Sep 2023 | 150k | $302k |
| Brighton Jones | Sep 2023 | 32k | $65k |
| Marquette Asset Management | Sep 2023 | 31k | $62k |
| D. E. Shaw & Co | Sep 2023 | 30k | $61k |
| Algert Coldiron Investors | Sep 2023 | 28k | $56k |
| Squarepoint Ops | Sep 2023 | 11k | $22k |
| Ohio Pers | Sep 2023 | 9.2k | $19k |
| Pnc Financial Services | Sep 2023 | 1.5k | $3.0k |